| Literature DB >> 35093155 |
Yuanting Chen1, Huacong Huang2, Gaoxing Li2, Jianyu Yu2, Fuchun Fang3, Wei Qiu4.
Abstract
Stem cells transplantation is the main method of tissue engineering regeneration treatment, the viability and therapeutic efficiency are limited. Scaffold materials also play an important role in tissue engineering, whereas there are still many limitations, such as rejection and toxic side effects caused by scaffold materials. Cell sheet engineering is a scaffold-free tissue technology, which avoids the side effects of traditional scaffolds and maximizes the function of stem cells. It is increasingly being used in the field of tissue regenerative medicine. Dental-derived mesenchymal stem cells (DMSCs) are multipotent cells that exist in various dental tissues and can be used in stem cell-based therapy, which is impactful in regenerative medicine. Emerging evidences show that cell sheets derived from DMSCs have better effects in the field of regenerative medicine applications. Extracellular matrix (ECM) is the main component of cell sheets, which is a dynamic repository of signalling biological molecules and has a variety of biological functions and may play an important role in the application of cell sheets. In this review, we summarized the application status, mechanisms that sheets and ECM may play and future prospect of DMSC sheets on regeneration medicine.Entities:
Keywords: Cell sheets; Decellularized; Dental-derived mesenchymal stem cells; Regenerative medicine
Mesh:
Year: 2022 PMID: 35093155 PMCID: PMC8800229 DOI: 10.1186/s13287-022-02716-3
Source DB: PubMed Journal: Stem Cell Res Ther ISSN: 1757-6512 Impact factor: 6.832
Fig. 1Schematic flowchart representing study inclusion
Fig. 2The origins, cell sheets preparation and decellularization of dental-derived mesenchymal stem cells (DMSCs). Dental-derived mesenchymal stem cells (DMSCs) consist of dental pulp stem cells (DPSCs), stem cells from human exfoliated deciduous teeth (SHED), periodontal ligament stem cells (PDLSCs), dental papilla stem cells (SCAPs), gingival mesenchymal stem cells (GMSCs), dental follicle stem cells (DFSCs), tooth germ stem cells (TGSCs) and alveolar bone-derived mesenchymal stem cells (ABMSCs). There are four common ways to harvest mature cell sheets: temperature-responsive polymer; other surface modification; non-surface modification methods; and adding a certain concentration of L-Ascorbic acid to the cell culture medium. The decellularized extracellular matrix (dECM) was obtained after processing to remove cells
Fig. 3DMSC sheets in different tissues regeneration. DPSC sheets application dental tissue, bone, nervous system and cornea regeneration; PDLSC sheets application dental tissue, bone and cornea regeneration; SHED sheets application dental root regeneration; DFSC sheets application periodontal tissue regeneration; ABMSC sheets application bone regeneration. ① Bone; ② Nervous system; ③ Cornea; ④ Root; ⑤ Dental pulp; ⑥ periodontal tissue. The elements of bone, nervous system and cornea were obtained from the Smart Servier website: https://smart.servier.com/
Regeneration of DMSC sheets in different study models
| Dental stem cells | Tissue regeneration | Study model | Effect | Additional treatment | Cell sheet pretreatment time | Treatment time | References |
|---|---|---|---|---|---|---|---|
| DPSCs | Dental tissue | Immunodeficient mice subcutaneous space | Pulp-like tissue was observed in root canal | Rod-like structure based on single layer cell sheet | 4 days | 6 weeks | Itoh et al. [ |
| Swine experimental periodontal bone defects | Alveolar bone and soft tissue recovered significantly | – | 10–15 days | 12 weeks | Hu et al. [ | ||
| Root | Periodontal tissue-like fibres, dentin formation | TDM | – | 12 weeks | Meng et al. [ | ||
| Immunodeficient mice subcutaneous | Higher blood-perfused vessel density | Recellularization and decellularization | 14 days | 30 days | Alghutaimel et al. [ | ||
| Beagle dogs root canal | Neovascularization, formation of dental Pulp-like tissues and mineralized structures | Decellularization | – | 8 weeks | Alqahtani et al. [ | ||
| Bone | Mouse calvarial defects | Bone regeneration, cell sheet was in situ whole period | TH | 14 days | 8 weeks | Fujii et al. [ | |
| Mouse calvarial defects | New bone formation, osteogenic differentiation in vitro | TH | 14 days | 8 weeks | Sato et al. [ | ||
| In vitro | More osteoblasts, bone matrix protein and calcified matrix moved to bone defect | Spherical tissue-engineered structure | 5 weeks | – | Tatsuhiro et al. [ | ||
| Facial nerve | Rat facial nerve crush injury | Promoted axon extension, enhanced nerve regeneration | – | 10–12 days | 3 weeks | Ahmed et al. [ | |
| Corneal | Rabbits LSCD | Functional regeneration and transparency of damaged corneas; expressed limbal stem cell markers | – | 3 days | 3 months | Gomes et al. [ | |
| PDLSCs | Periodontal tissue | Sheep mandible periodontal defects | Alveolar bone, thin cementum and periodontal fibres regeneration | Biphasic scaffold | 7 days | 5 and 10 weeks | Vaquette et al. [ |
| Immunodeficient mice dorsal surface | PDL-like dense collagen fibres, vascular regeneration | Titanium rod | 6–10 days | 8 weeks | Gao et al. [ | ||
| Immunodeficient mice subcutaneous implantation | PDL-like fibrous structure and mineralized tissue formation | Self-form cylindrical structure | 7/14 days | 4 weeks | Basu et al. [ | ||
| Nude mice subcutaneous | Cementum-like mineralized tissue and vertical or oblique insertion of collagen fibre onto the MBCP structure surface | rhBMP-2 | 14 days | 4 weeks | Park et al. [ | ||
| Beagle dogs mandibular bone defect | PDL-like fibrous tissue was observed on the surface of the implant | Titanium rod | 10 days | 6 weeks | Washio et al. [ | ||
| Bone | Nude mice subcutaneous | Promote PDLSC proliferation, induce osteogenic differentiation and bone-like tissues | PRF | 14 days | 8 weeks | Wang et al. [ | |
| Nude mice dorsa | Osteogenic related genes and proteins significantly improved; more bone formation | Osthole | 10 days | 4 weeks | Gao et al. [ | ||
| Nude mice dorsa | More new bone formation | AuNPs | 7 days | 4/8 weeks | Zhang et al. [ | ||
| Nude mice subcutaneous | Osteogenic differentiation was improved | Indirectly cocultured | 10 days | 6 weeks | Wu et al. [ | ||
| Rat maxillary defects and immunocompromised mice subcutaneous | More COL4A2 expression, more compact, thicker newly formed bone, thicker and denser collagen fibres | PDLSC cultured on B-dECM or P-dECM | 10 days | 8 weeks | Wen et al. [ | ||
| Corneal | In vitro | Promote PDLSC differentiated into keratinocytes | Mechanical stimulation | 12 days | – | Li et al. [ | |
| DFSCs | Periodontal tissue | Rat omenta | Cementum and periodontal ligament-like tissue regeneration | Co-cultured with HERS | 3 weeks | 5 weeks | Bai et al. [ |
| Nude mice under the renal capsule | Periodontal ligament, cementum and alveolar bone regeneration | DDM | 9–11 days | 4 and 8 weeks | Feng et al. [ | ||
| Rat calvarial bone defect | New bone, periodontal-like tissues formation | – | 2 weeks | 2, 4, and 8 weeks | Yang et al. [ | ||
| ABMSCs | Bone | Rabbit bone defect | Bone-like tissue formation | – | 10 days | 4 weeks | Liu et al. [ |
| SHED | Root | Rats jaw bone defect | ALP, OCN and BSP expression were up-regulated, dentin and periodontal tissue regeneration | – | 14 days | 8 weeks | Yang et al. [ |
ABMSCs alveolar bone-derived mesenchymal stem cells, ALP alkaline phosphatase, AuNPs gold nanoparticles, B-dECM decellularized bone marrow mesenchymal stem cell extracellular matrix, BSP bone sialoprotein, COL4A2 type IV collagen A2, DDM decalcified dentin matrix, DFSCs dental follicle stem cells, DPSCs dental pulp stem cells, LSCD limbal stem cell deficiency, MBCP micro-/macro-porous biphasic calcium phosphate, OCN osteocalcin, P-dECM decellularized periodontal ligament stem cells extracellular matrix, PDL periodontal ligament, PDLSCs periodontal ligament stem cells, PRF platelet-rich fibrin, SHED stem cells from human exfoliated deciduous teeth, TDM-treated dentin matrix, TH 4-(4-Methoxyphenyl) pyrido [40,30:4,5] thieno [2,3-b] pyridine-2-carboxamide